Advertisement

Search Results for "Abbott Duodopa Fda Approval"

12:03 EDT 19th May 2013 | BioPortfolio

Matching Channels

Abbott

The 11th largest pharmaceutical company in the world, Abbott Laboratories generated sales of $16 billion in 2009 and has 90,000 employees. Within the medical device arm of the company, products of...

Urokinase Abbott

Abiraterone Acetate - Zytiga

On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...

Clinical Trials Phase News

Clinical trials involving new drugs are commonly classified into four phases. Each phase of the drug approval process is treated as a separate clinical trial. The drug-development process will norma...

Clinical Approvals - news, views, reports and blogs

Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and eff...

Matching News

Intestinal Levodopa-Carbidopa for Parkinson’s Reduced ‘Off’ Time

Phase III data on Abbott’s Duodopa were presented at the American Academy of Neurology.

BRIEF-Abbott's Humira wins EU approval for new use

Nov 27 (Reuters) - Abbott Laboratories : * Abbott's Humira (adalimumab) approved in Europe for severe active pediatric

Abbott, Sucampo receive Japanese approval for AMITIZA

Sucampo Pharmaceuticals, Inc. and Abbott today announced that Sucampo Pharma, Ltd., a wholly owned subsidiary of SPI, has received approval from the Ministry of Health, Labor and Welfare in Japan for...

Abbott gets FDA approval for cataract surgery gel

Abbott Laboratories said Tuesday that it received U.S. regulatory approval for a product used to protect the eye in cataract surgery.The Food and Drug Administration approved the company's Healon End...

Abbott's heart stent gains FDA approval

The FDA has granted Abbott Laboratories approval for its Xience Xpedition system, which the company said is targeted for imme -More- 

UPDATE 1-FDA staff does not recommend approval of Abbott's heart device

March 18 (Reuters) - Staff reviewers for the U.S. Food and Drug Administration did not recommend the approval of Abbott Laboratories' implantable heart device MitraClip, citing a lack of "valid scient...

EU Commission approves Bayer's Eylea for wet AMD and Abbott's Humira for pediatric Crohn's

There was good news yesterday for Germany's Bayer (BAYN: DE) and US health care major Abbott Laboratories (NYSE: ABT), when the European Commission announced final approval for the former's ophthalmic...

FDA advisers vote for approval of Abbott's implantable heart device

(Reuters) - A slim majority of advisers to the U.S. Food and Drug Administration voted on Wednesday for approval of Abbott Laboratories' implantable heart device MitraClip, saying it had more benefits...

Matching PubMed Articles

Abbott Physicochemical Tiering (APT)-A unified approach to HTS triage.

The selection of the highest quality chemical matter from high throughput screening (HTS) is the ultimate aim of any triage process. Typically there are many hundreds or thousands of hits capable of m...

Exploration of diverse hinge-binding scaffolds for selective Aurora kinase inhibitors.

Four hinge-binding scaffolds have been explored for novel selective Aurora kinase inhibitors. The structure activity relationship, selectivity and pharmacokinetic profiles have been evaluated.

Assessing renal function: Some significant improvements on the horizon.

Diaryldiamines with Dual Inhibition of the Histamine H(3) Receptor and the Norepinephrine Transporter and the Efficacy of 4-(3-(Methylamino)-1-phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol in Pain.

A series of compounds was designed as dual inhibitors of the H(3) receptor and the norepinephrine transporter. Compound 5 (rNET K(i) = 14 nM; rH(3)R K(i) = 37 nM) was found to be efficacious in a rat...

Discovery of diphenyl lactam derivatives as N-type calcium channel blockers.

A novel series of diphenyl lactam containing calcium channel blockers is described. Extensive SAR studies resulted in compounds with low molar activity and good plasma exposure after oral dosing. Comp...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement